BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14751251)

  • 1. Clinico-molecular study of dedifferentiation in well-differentiated liposarcoma.
    Shimoji T; Kanda H; Kitagawa T; Kadota K; Asai R; Takahashi K; Kawaguchi N; Matsumoto S; Hayashizaki Y; Okazaki Y; Shinomiya K
    Biochem Biophys Res Commun; 2004 Feb; 314(4):1133-40. PubMed ID: 14751251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
    He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
    Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.
    Beird HC; Wu CC; Ingram DR; Wang WL; Alimohamed A; Gumbs C; Little L; Song X; Feig BW; Roland CL; Zhang J; Benjamin RS; Hwu P; Lazar AJ; Futreal PA; Somaiah N
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
    Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-differentiated liposarcoma (atypical lipomatous tumors).
    Laurino L; Furlanetto A; Orvieto E; Dei Tos AP
    Semin Diagn Pathol; 2001 Nov; 18(4):258-62. PubMed ID: 11757865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.
    Singer S; Socci ND; Ambrosini G; Sambol E; Decarolis P; Wu Y; O'Connor R; Maki R; Viale A; Sander C; Schwartz GK; Antonescu CR
    Cancer Res; 2007 Jul; 67(14):6626-36. PubMed ID: 17638873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaic-pattern dedifferentiation in liposarcoma and chondrosarcoma: imaging features of an uncommon form of dedifferentiation.
    Taylor K; Kransdorf MJ; Schwartz AJ; O'Connor MI; Zarka MA
    Skeletal Radiol; 2018 Jun; 47(6):877-882. PubMed ID: 29362843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
    Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
    Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile‑driven discovery of AURKA as a treatment target for liposarcoma.
    Yen CC; Chen SC; Hung GY; Wu PK; Chua WY; Lin YC; Yen CH; Chen YC; Wang JY; Yang MH; Chao Y; Chang MC; Chen WM
    Int J Oncol; 2019 Oct; 55(4):938-948. PubMed ID: 31485600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas.
    Schneider-Stock R; Boltze C; Jaeger V; Stumm M; Seiler C; Rys J; Schütze K; Roessner A
    J Pathol; 2002 Aug; 197(5):654-60. PubMed ID: 12210086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
    Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
    Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
    Hisaoka M; Matsuyama A; Nakamoto M
    Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposarcoma: new entities and evolving concepts.
    Dei Tos AP
    Ann Diagn Pathol; 2000 Aug; 4(4):252-66. PubMed ID: 10982304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas.
    Deyrup AT; Chibon F; Guillou L; Lagarde P; Coindre JM; Weiss SW
    Am J Surg Pathol; 2013 Sep; 37(9):1373-8. PubMed ID: 23887155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in Liposarcoma.
    Tseng WW; Chopra S; Engleman EG; Pollock RE
    Front Oncol; 2016; 6():134. PubMed ID: 27376027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
    Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
    Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
    Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
    Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.
    Schneider-Stock R; Gerresheim F; Kolin-Gerresheim I; Meyer F; Jäger V; Epplen JT; Roessner A; Boltze C
    Pathol Res Pract; 2003; 199(6):445-50. PubMed ID: 12924448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.
    Boltze C; Schneider-Stock R; Jäger V; Roessner A
    Pathol Res Pract; 2001; 197(8):563-8. PubMed ID: 11518050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.